|
|
||||||||
| Neurology supplements are not peer-reviewed. Information contained in Neurology supplements represent the opinions of the authors and are not endorsed by nor do they reflect the views of the American Academy of Neurology, Editor-in-Chief, or Associate Editors of Neurology. |
From the University of Miami School of Medicine, Miami, FL (Dr. Ramsay), Mount Sinai Medical Center, Bronx, NY (Dr. Rowan), and Miami VA Medical Center, Miami, FL (Ms. Pryor).
Address correspondence and reprint requests to Dr. R. Eugene Ramsay, Director, International Center for Epilepsy, Professor of Neurology and Psychiatry, University of Miami School of Medicine, Professional Arts Center, Suite 410, 1150 N.W. 14th Street, Miami, FL 33136.
Epilepsy in elderly patients, compared with the younger adult population, differs in etiology, clinical presentation, and prognosis. Challenges in the pharmacologic treatment of epilepsy in the elderly include the following: the physiologic changes associated with aging; adverse events to which the elderly are especially vulnerable; the increased risk for these patients, who are often taking multiple medications; and toxicity from drugdrug interactions. This article presents data on efficacy and safety from clinical trials of newer antiepileptic drugs (AEDs) in elderly patients compared with older AEDs. We discuss the implications of the findings using newer-generation AEDs in the Veterans Affairs Cooperative Study (VACS) #428 in order to educate physicians involved in choosing appropriate AEDs for older patients. In the elderly patient population, an optimal treatment outcome of seizure control with minimal or no adverse events is dependent on the well-informed choice of an AED by a physician.
This article has been cited by other articles:
![]() |
M.J.V. Pugh, A. C. Van Cott, J. A. Cramer, J. E. Knoefel, M. E. Amuan, J. Tabares, R. E. Ramsay, D. R. Berlowitz, and Treatment In Geriatric Epilepsy Research (TIGER) t Trends in antiepileptic drug prescribing for older patients with new-onset epilepsy: 2000-2004 Neurology, May 27, 2008; 70(22_Part_2): 2171 - 2178. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Chihorek, B. Abou-Khalil, and B. A. Malow Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy Neurology, November 6, 2007; 69(19): 1823 - 1827. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pellock Overview: Definitions and Classifications of Seizure Emergencies J Child Neurol, May 1, 2007; 22(5_suppl): 9S - 13S. [Abstract] [PDF] |
||||
![]() |
R. E. Ramsay, W. D. Shields, and S. Shinnar Special Issues in the Management of Young Children, Older Adults, and the Developmentally Disabled J Child Neurol, May 1, 2007; 22(5_suppl): 53S - 60S. [Abstract] [PDF] |
||||
![]() |
P. Ryvlin, A. Montavont, and N. Nighoghossian Optimizing therapy of seizures in stroke patients Neurology, December 26, 2006; 67(12_suppl_4): S3 - S9. [Abstract] [Full Text] |
||||
![]() |
R. D. Sheth, J. F. Drazkowski, J. I. Sirven, B. E. Gidal, and B. P. Hermann Protracted ictal confusion in elderly patients. Arch Neurol, April 1, 2006; 63(4): 529 - 532. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R Garnett Optimizing Antiepileptic Drug Therapy in the Elderly Ann. Pharmacother., November 1, 2005; 39(11): 1852 - 1860. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Anderson Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs Neurology, November 23, 2004; 63(10_suppl_4): S3 - S8. [Abstract] [Full Text] |
||||
![]() |
G. K. Bergey Initial treatment of epilepsy: Special issues in treating the elderly Neurology, November 23, 2004; 63(10_suppl_4): S40 - S48. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |